One study demonstrated that, in the context of diabetes, BBR reduces fibronectin (FN) expression in mesangial cells by targeting the sphingosine 1-phosphate (S1P) receptor subtype 2, an effect potentially linked to its suppression of NF-κB activation (Huang et al., 2012). This evidence concerns the gene FN1 and diabetes mellitus.